NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Journal: Nature

Published: 2021-03-24

DOI: 10.1038/s41586-021-03362-0

Affiliations: 87

Authors: 110

Go to article
Institutions Share
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.13
University Hospital Zurich (UHZ), Switzerland 0.06
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.05
Newcastle University, United Kingdom (UK) 0.05
University Hospital Tübingen (UKT), Uni Tübingen, Germany 0.04
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.03
University of Zurich (UZH), Switzerland 0.03
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.03
IRCCS Humanitas Research Hospital, Italy 0.03
University Medical Center Mainz, JGU, Germany 0.03
Weizmann Institute of Science (WIS), Israel 0.03
University Hospital Frankfurt, GU, Germany 0.03
Medical University of Vienna (MUW), Austria 0.03
Technical University of Munich (TUM), Germany 0.02
German Rheumatism Research Centre Berlin (DRFZ), Germany 0.02
University of Cologne (UoC), Germany 0.02
Massachusetts General Hospital (MGH), United States of America (USA) 0.02
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.02
Heidelberg University (Uni Heidelberg), Germany 0.02
Spanish National Cancer Research Centre (CNIO), Spain 0.02
Klinikum Klagenfurt am Wörthersee, Austria 0.02
University of Tübingen (Uni Tübingen), Germany 0.02
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany 0.01
Hannover Medical School (MHH), Germany 0.01
Max Planck Institute of Biochemistry, Germany 0.01
Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany 0.01
TUM University Hospital Klinikum rechts der Isar (MRI), Germany 0.01
Institute for Advanced Biosciences (IAB), France 0.01
Grenoble Alpes University (UGA), France 0.01
Oncology Institute of Southern Switzerland (IOSI), Switzerland 0.01
Kindai University, Japan 0.01
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.01
NIHR Cambridge Biomedical Research Centre (Cambridge BRC), United Kingdom (UK) 0.01
Heinrich Heine University Düsseldorf (HHU), Germany 0.01
University of Florence (UNIFI), Italy 0.01
DKFZ-ZMBH Alliance, Germany 0.01
Addenbrooke's Hospital, United Kingdom (UK) 0.01
Humanitas University, Italy 0.01
A.O.U. Citta della Salute e della Scienza di Torino, Italy 0.01
University of Turin (UNITO), Italy 0.01
Hammersmith Hospital, Imperial College Healthcare NHS Trust, United Kingdom (UK) 0.01
Imperial College London (ICL), United Kingdom (UK) 0.01
Cornell University, United States of America (USA) 0
NIHR Newcastle Biomedical Research Centre, United Kingdom (UK) 0
AP-HP Beaujon Hospital, France 0
University of Paris, France 0
Taipei Veterans General Hospital (TPEVGH), Taiwan 0
National Yang Ming Chiao Tung University (NYCU), Taiwan 0
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0
Aretaieio Hospital, UOA, Greece 0
Mount Sinai Hospital, ISMMS, United States of America (USA) 0
University of Bern (UniBE), Switzerland 0
Bern University Hospital, Switzerland 0
University Medical Center Schleswig-Holstein - Campus Kiel (UKSH Kiel), Germany 0
DKTK Partner Site Munich, Germany 0
DZIF Partner Site Munich, Germany 0
Alps Grenoble University Hospital (CHU Grenoble Alpes), France 0
Institute of Virology, Germany 0
University of Eastern Piedmont "Amedeo Avogadro" (UNIPMN), Italy 0
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0
DKTK Partner Site Tuebingen, Germany 0

Return